Belzutifan plus lenvatinib show promise as a second-line treatment for advanced kidney cancer
A recent study, called the Phase 3 LITESPARK-011 trial, looked [...]
Pembrolizumab plus belzutifan combination shows promise as an adjuvant treatment for kidney cancer
A large phase 3 clinical trial tested two medicines, pembrolizumab [...]
Kidney Cancer Highlights from ESMO 2025
This year’s European Society for Medical Oncology (ESMO) Congress was [...]
NHS Healthy Choices Quiz
Action Kidney Cancer are supporting the Department of Health and [...]
Kidney cancer microscope cuts patient waits in Cambridge
The kidney cancer clinic at Addenbrooke's Hospital in Cambridge is [...]
New treatment, casdatifan, shows promise in previously treated kidney cancer
A new treatment called casdatifan showed promising responses in a [...]
Bevacizumab plus erlotinib shows antitumor activity in advanced papillary kidney cancer
A recent phase 2 study, published in the New England [...]
Coalition for Reducing Bureaucracy in Clinical Trials 2025 Recommendations
All medicines need to pass rigorous tests before they can [...]
Kidney cancer cases are projected to double by 2050
Lifestyle risk factors such as obesity, smoking, lack of exercise, [...]
Cancer waiting times: Latest updates
Recent years have seen pressure on NHS cancer services increase, [...]
